Two-Year Data From a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age

Advances in Therapy - United States
doi 10.1007/s12325-016-0301-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC